In this issue:
Effect of zoledronic acid for treatment of knee OA with bone marrow lesions
Guselkumab in biologic-naive patients with active PsA
Secukinumab immunogenicity in patients with PsA and AS
Effect of OA on work participation and loss of working life-years
Predictors of fatigue in symptomatic knee OA
Risk of neuroinflammatory events in arthritis patients treated with TNFis
Neutralisation of IL-17A and IL-17F with bimekizumab in active AS
Impact of the new BP definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus
Dapansutrile for treatment of gout flares
Please login below to download this issue (PDF)